Thermo Fisher Scientific(US:TMO) Financial Modeling Prepยท2025-10-22 16:00Core Insights - Thermo Fisher Scientific Inc. reported strong financial results for the third quarter, with earnings per share (EPS) of $5.79, exceeding the estimated $5.50 [1][5] - The company's revenue reached approximately $11.12 billion, surpassing the forecasted $10.91 billion, reflecting a 5% increase [2][5] - The adjusted EPS grew by 10%, indicating improved profitability while maintaining a consistent GAAP diluted EPS of $4.27 from the previous year [2] Financial Metrics - The company has a price-to-earnings (P/E) ratio of about 32.04, indicating investor willingness to pay for earnings [3] - The price-to-sales ratio is approximately 4.88, and the enterprise value to sales ratio stands at 5.59 [3] - The enterprise value to operating cash flow ratio is around 31.85, providing insight into the company's valuation [3] Financial Stability - Thermo Fisher's earnings yield is 3.12%, reflecting earnings generated from each dollar invested in its stock [4] - The company maintains a moderate debt-to-equity ratio of 0.70, indicating a balanced level of debt relative to equity [4] - A current ratio of 1.93 demonstrates a strong ability to cover short-term liabilities with short-term assets, showcasing financial stability [4][5]